Rhythm Pharmaceuticals Total Assets (Quarterly) Insights

Rhythm Pharmaceuticals Inc (RYTM)

59.96 +0.93 (+1.58%) USD | NASDAQ | Nov 22, 11:33

Total Assets (Quarterly) Chart

Historical Total Assets (Quarterly) Data

View and export this data back to 2016. Upgrade now.

Date	Value
September 30, 2024	363.57M
June 30, 2024	381.85M
March 31, 2024	258.65M
December 31, 2023	332.74M
September 30, 2023	354.20M
June 30, 2023	309.94M
March 31, 2023	345.68M
December 31, 2022	382.48M
September 30, 2022	389.61M
June 30, 2022	277.68M
March 31, 2022	284.82M
December 31, 2021	329.52M
September 30, 2021	355.82M
June 30, 2021	388.39M
March 31, 2021	422.21M
December 31, 2020	187.07M

Date	Value
September 30, 2020	215.48M
June 30, 2020	243.48M
March 31, 2020	273.76M
December 31, 2019	308.52M
September 30, 2019	177.53M
June 30, 2019	210.89M
March 31, 2019	236.50M
December 31, 2018	260.21M
September 30, 2018	277.73M
June 30, 2018	291.75M
March 31, 2018	139.44M
December 31, 2017	151.74M
September 30, 2017	34.80M
June 30, 2017	40.88M
December 31, 2016	12.34M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

187.07M

Minimum

Dec 2020

422.21M

Maximum

Mar 2021

320.27M

Average

331.13M

Median

Total Assets (Quarterly) Benchmarks

Eli Lilly and Co	75.61B
TG Therapeutics Inc	586.01M
Regeneron Pharmaceuticals Inc	37.44B
Voyager Therapeutics Inc	426.04M
Krystal Biotech Inc	982.32M

Total Assets (Quarterly) Related Metrics

Total Liabilities (Quarterly)	352.36M
Shareholders Equity (Quarterly)	11.22M
Current Ratio	3.487